Life After the Grant: Building Funding Resilience When Donor Support Falls Away
A district health office in Zambia receives a stop-work notice on a Friday afternoon. By Monday morning the queue outside the antiretroviral clinic has formed exactly as it does every week, indifferent to any decision taken in Washington. The people in that queue are the reason the notice cannot be where the conversation ends.
For much of 2025, health leaders across sub-Saharan Africa lived inside that gap: the distance between a funding decision made in one capital and a clinic door that still has to open in another. The question facing them is no longer whether external funding will always be there. It is how an organisation keeps serving people when a single source of money can be switched off in a week.
Rebuilding from that position is not a matter of finding one replacement cheque. It follows an order. Stabilise what cannot be lost, diversify with intent, prove your value to a more demanding class of funder, and build the kind of resilience that treats the next shock as something you planned for rather than something you react to.
How a single donor became a structural risk, not a safety net
For years, external aid functioned as the backbone of many national health programmes rather than a top-up to them. When one donor funds the testing, the treatment, and the supply chain that moves the medicines, its withdrawal is not a budget gap. It is a fault line running straight through service delivery.
The scale of that exposure became visible once the funding paused. Roughly 37 low- and middle-income countries relied on US aid for more than 10% of their health budgets, and in Zambia specifically, a facility-level study found that 71% of healthcare facilities experienced changes tied to the funding cuts within three to four months. The disruption reached staff, partnerships, and the commodities patients depend on. The human cost of interrupted HIV, TB, and malaria services is real and well documented, which is precisely why the operational response matters so much.
The uncomfortable insight is that this exposure was always structural. The shock did not create the dependency; it revealed one that had been designed into programmes over two decades. That reframing is useful, because a structural problem can be corrected by design. Treating the withdrawal as bad luck leads an organisation to wait for the money to return. Treating it as a design flaw leads it to build something sturdier.
What to stabilise first: triage before you diversify
Before chasing new funding, protect what cannot be rebuilt. That means the continuity of life-critical services such as antiretroviral and TB treatment, the commodity pipeline that supplies them, and the core technical staff who run them. Diversification takes months to bear fruit. A treatment interruption takes days to cause harm.
The organising principle is triage by irreversibility, not by programme size or donor visibility. A large, well-branded awareness campaign can pause and restart with limited lasting damage. A patient whose antiretroviral therapy is interrupted, or a cold chain that fails, produces harm that no later funding can undo. When resources are suddenly scarce, the instinct is to defend the most visible programme. The discipline is to defend the most irreversible harm.
In practice, stabilisation in the first weeks tends to concentrate on a short list: uninterrupted supply of essential medicines, buffer stock where the pipeline is fragile, functioning cold chain, and the retention of a minimum technical team that holds the institutional knowledge. Supply disruptions and stock-outs were among the earliest consequences reported after the cuts, which makes the commodity pipeline the part of the system least safe to assume will hold on its own. Everything in the sections that follow depends on the services surviving long enough for a new funding base to take shape.
The diversification menu: matching funding mechanisms to your organisation
Diversification is not simply adding more donors. It is matching each funding mechanism to your organisation's type and time horizon, because a short-term cash bridge and a long-term structural fix are different instruments that solve different problems. Reaching for the wrong one at the wrong moment wastes the scarcest resource you have, which is time.
The mechanisms now in serious discussion across the sector range from the immediate to the deeply structural. Governments are assessing how to raise domestic spending and build health sovereignty, and the emerging US posture itself now negotiates bilateral agreements that require co-investment from recipient countries. Alongside these sit multilateral funds, debt-based instruments, and newer channels. A debt-to-health swap, for instance, forgives a portion of national debt in exchange for domestic health investment, and has been used in agreements between Spain and Cameroon, Ethiopia, and the DRC to support HIV, TB, and malaria programmes.
Mechanism
Best-fit context
Realistic time-to-cash
What it asks of you
Domestic budget reallocation / co-investment
Government-linked programmes, MoH partners
Medium (tied to budget cycles)
Alignment with national plans, evidence of value-for-money
Global Fund / Gavi
HIV, TB, malaria, immunisation
Medium to long (grant cycles)
Strong M&E, co-financing commitments
Debt-to-health swaps
National and multilateral level
Long
Government and creditor negotiation
Climate financing (e.g. Green Climate Fund)
Health and climate intersections (WASH, resilience)
Long
Framing health within a climate mandate
Health taxes (tobacco, alcohol, sugar)
National fiscal policy
Long
Legislative change and domestic political will
Private sector / CSR / blended finance
Service delivery with a commercial adjacency
Variable
A viable partnership or revenue model
South-South / pan-African cooperation
Technical capability sharing
Variable
Regional relationships and shared priorities
The pattern worth noticing is that peer countries are already moving. Some have introduced supplemental domestic health budgets to cushion the immediate gap. The organisations that navigate this well tend to run two tracks at once: a near-term bridge to keep services alive, and a slower structural shift that reduces dependency for good. Confusing the two, and expecting a debt swap or a health-tax reform to solve a cash crisis this quarter, is a common and costly mistake.
How to prove impact to co-investment funders
The new funding era rewards evidence. Co-investment and bilateral agreements shift scrutiny towards what each dollar actually delivers, which means the organisations that endure are those that can show outcomes per dollar rather than activities completed. Measurement stops being a reporting chore and becomes the argument for your next tranche of funding.
This is a genuine change in what a funder wants to see. When aid flowed on the assumption of continuity, a clean activity report was often enough. When a government is co-investing its own constrained budget, and a bilateral agreement is built around monitoring plans and a path to self-reliance, the question sharpens to value-for-money. Funders increasingly want routine data systems that produce timely numbers, continuous quality improvement loops that show services getting better over time, and unit-cost reporting that makes the return on their money legible.
For most organisations this is less about buying new software and more about disciplined use of the data they already collect. An organisation that can state, with evidence, what it costs to keep one patient on treatment for a year, and how that cost has fallen as processes improved, is holding the single most persuasive document in a co-investment negotiation. This is where a strong monitoring and evaluation function stops being compliance overhead and starts earning the organisation its future.
Designing for the next shock: resilience as a capability, not a fund
Resilience is not a replacement grant waiting to be found. It is a set of capabilities: programmes integrated into the national health system, supply chains that can absorb a shock, and a local workforce that carries institutional knowledge regardless of who funds this year's activities. A fund can be withdrawn. A capability, once built, stays.
The evidence points in a consistent direction. The same Zambian research that measured the disruption also identified the way through it, recommending the integration of donor programmes into the existing health system, sustained supply chain strengthening, and health workforce capacity-building as the foundations of long-term programme sustainability. Parallel funding structures that run alongside the national system are the first thing to collapse when the parallel funding stops. Programmes built inside the system are far harder to switch off.
This is the deeper meaning of self-reliance, and it aligns with a shift the whole sector is being pushed towards. It also reframes the immediate crisis as an opening. An organisation that uses this period to embed its work in national structures, strengthen the local supply chain, and deepen its own team's capability is not merely surviving the loss of a donor. It is building the thing that should have been built all along, and doing it with a clarity of purpose that abundant funding rarely forces.
Frequently Asked Questions
How can we replace lost USAID funding? No single source replaces it, and planning as though one will is the first error to avoid. The workable path combines domestic budget reallocation, multilateral funds such as the Global Fund and Gavi, and structural mechanisms like debt-to-health swaps, sequenced by urgency. A near-term cash bridge keeps services alive while slower structural funding is arranged.
What is a debt-to-health swap? It is an arrangement in which a creditor forgives a portion of a country's debt on the condition that the freed resources are invested in health. It converts a debt-servicing burden into domestic health funding, and has been used to support HIV, TB, and malaria programmes in several countries. It operates at national level and takes time to negotiate.
Where should we start this quarter? Start with triage, not fundraising. Protect the continuity of life-critical services and the commodity pipeline first, then map exactly where your organisation is exposed to a single funding source. Only once services are stable should the diversification conversations begin in earnest. Stabilise, map, then diversify.
How much of donor funding can realistically shift to domestic sources? It depends heavily on a country's fiscal space, and high debt-servicing costs constrain many low- and middle-income countries. For most, the realistic near-term goal is partial substitution combined with efficiency gains, not full replacement. Domestic financing is a direction of travel to build towards deliberately, not a switch to flip in a single budget year.
Key Takeaways
The organisations that come through this transition intact are rarely the ones that found the biggest replacement grant. They are the ones that acted in the right order, protecting what could not be lost before reaching for what might be gained. Funding resilience is built as a sequence, and the sequence is the strategy.
- Dependency is structural, so treat it as a design problem. The shock revealed an exposure that was always there. It can be corrected by design rather than waited out.
- Triage by irreversibility first. Defend life-critical service continuity, the commodity pipeline, and core technical staff before pursuing any new funding.
- Match the mechanism to the need. A short-term cash bridge and a long-term structural fix are different instruments. Run both tracks, and do not expect one to do the other's job.
- Make your evidence your case. Co-investment funders fund outcomes per dollar. Routine data, quality-improvement loops, and unit-cost clarity are now survival tools.
- Build capabilities, not just funds. Integration into national systems, resilient supply chains, and local workforce capacity are what remain when a donor leaves.
Building a funding-transition plan while simultaneously keeping services running is genuinely difficult, and few teams have the bandwidth to do both well at once. This is the work ChainOptix's Business Advisory service is built for: strategic guidance, compliance, and capacity building for organisations navigating exactly this kind of transition. If your team is mapping its own path to self-reliance, we would welcome the conversation.
